<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-ZIWDALNK</identifier><date>2022</date><creator>Čebron Lipovec, Nanča</creator><creator>Kos, Mitja</creator><creator>Prelesnik, Sara</creator><relation>documents/doc/Z/URN_NBN_SI_doc-ZIWDALNK_001.pdf</relation><relation>documents/doc/Z/URN_NBN_SI_doc-ZIWDALNK_001.txt</relation><format format_type="issue">3</format><format format_type="volume">73</format><format format_type="type">article</format><format format_type="extent">str. 199-209</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">115498755</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-ZIWDALNK</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">Farmakovigilanca</subject><subject language_type_id="slv">farmakovigilančni ukrep</subject><subject language_type_id="slv">Nosečnost</subject><subject language_type_id="slv">retinoidi</subject><subject language_type_id="slv">teratogenost</subject><title>Awareness of pharmacovigilance measures for safe use of retinoids among female patients, pharmacists and prescribers</title><title>Ozaveščenost pacientk, farmacevtov in predpisovalcev o farmakovigilančnih ukrepih za varno uporabo retinoidov</title></Record>